The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptorblocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reduced ejection fraction
Pankaj Jariwala,
Kartik Jadhav,
Jagdish Madireddi,
Anil Kulkarni,
Kashyap Vyas,
Arshad Punjani,
Harikishan Boorougu,
Dilip Babu Madhawar
Affiliations
Pankaj Jariwala
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Kartik Jadhav
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Jagdish Madireddi
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Anil Kulkarni
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Kashyap Vyas
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Arshad Punjani
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Harikishan Boorougu
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
Dilip Babu Madhawar
Department of Cardiology, Internal Medicine, Nephrology, Yashoda Hospitals, Somajiguda, Raj Bhavan Road, Hyderabad, Telangana, 500082 India
